Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves | Zendy

SunYoung Kim | Zendy; Joshua A. Salomon | Zendy; Sue J. Goldie | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves

Author(s) -

SunYoung Kim,

Joshua A. Salomon,

Sue J. Goldie

Publication year - 2007

Publication title -

bulletin of the world health organization

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.459

H-Index - 168

eISSN - 1564-0604

pISSN - 0042-9686

DOI - 10.2471/blt.06.038893

Subject(s) - cost effectiveness , medicine , economic evaluation , cost effectiveness analysis , cost–benefit analysis , vaccination , health care , incremental cost effectiveness ratio , actuarial science , environmental health , economic growth , economics , political science , virology , risk analysis (engineering) , pathology , law

We sought to describe a method that explicitly considers both a health-care programmes cost-effectiveness and its affordability. For illustration, we apply the method to the programme to vaccinate infants against hepatitis B in the Gambia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research